Background: Some children who are infected with human immunodeficiency virus type 1 (HIV-1) during the perinatal period remain asymptomatic for very long periods in the absence of antiretroviral treatment, as is the case for some adults. Our objective was to estimate the proportion of children who developed neither symptoms nor major immunological perturbations to the age of > or = 10 years in a prospective cohort of infected children who had been observed since birth.
Methods: The ongoing prospective French Pediatric Cohort includes 568 HIV-1-infected children. Here, we report the follow-up data for all 348 HIV-1-infected children who were born before 1 January 1994. Children with long-term nonprogression of infection (LTNPs) were defined as HIV-1-infected children who had been observed for at least 10 years, never received antiretroviral treatment other than zidovudine monotherapy, never developed symptoms of Centers for Disease Control and Prevention clinical category C or B, and had a CD4+ cell percentage of < 25% no more than once during follow-up. Other definitions were compared.
Results: The Kaplan-Meier estimate of long-term nonprogression was 2.4% (95% confidence interval, 1.1%-4.6%) at 10 years of age, and 7 children were classified as LTNPs. The Kaplan-Meier estimates decreased slightly with age, to 1.8% at 12 years of age and 1.4% at 14 years of age. Plasma HIV-1 replication rates were low (< 1000 copies RNA/mL) for 2 of the 7 LTNPs at the age of 10 years (0.6% of the total denominator). None of the routinely measured maternal or perinatal markers were significantly linked to long-term nonprogression, with the exception of the mother's Centers for Disease Control and Prevention clinical category at the time of delivery.
Conclusions: Approximately 2% of children who were infected during the perinatal period displayed no immunological or clinical progression by the age of 10 years. This figure is close to that reported for adults in studies that have used similar definitions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1086/521165 | DOI Listing |
Cureus
November 2024
Department of Ophthalmology, Unidade Local de Saúde (ULS) Santa Maria, Lisbon, PRT.
Benign yellow dot maculopathy (BYDM) is a recently described rare, asymptomatic, early onset, and non-progressive macular phenotype. It is characterized by the presence of multiple white-yellow dots encircling the fovea, which are hyperautofluorescent on fundus autofluorescence. Here, we expand on the few reports available by presenting a case series of five Portuguese patients with clinical BYDM phenotype and congruent multimodal imaging, including the second reported unilateral case.
View Article and Find Full Text PDFJ Endovasc Ther
November 2024
Vascular Center, Department of Thoracic Surgery and Vascular Diseases, Skåne University Hospital, Malmö, Sweden.
Eur J Orthop Surg Traumatol
November 2024
Granovsky Gluskin Orthopedic Division. Sinai Health System, Mount Sinai hospital, University of 476C-1, 600 University Avenue, Toronto, ON, M5G 1X5, Canada.
Cureus
October 2024
Department of Physiotherapy, KLE (Karnataka Lingayat Education) College of Physiotherapy, Hubli, IND.
Introduction Neurodevelopmental disorders (NDDs) are responsible for childhood brain dysfunction and developmental disability. Physical therapists are important team members in providing a beneficial impact on the gross motor function of children with NDDs. Early intervention provides a beneficial effect on the improvement of gross motor function; however, most of the studies on treadmill training were in late age and the effect of early treadmill walking along with conventional physiotherapy was not studied.
View Article and Find Full Text PDFMult Scler Relat Disord
November 2024
Department of Neuroscience, School of Translational Medicine, Monash University, Australia.
Background: Remote objective tests may supplement in-clinic examination to better inform treatment decisions. Previous cross-sectional studies presented objective speech metrics as potential markers of Multiple Sclerosis (MS) disease progression.
Objective: To examine the short-term stability and long-term sensitivity of speech metrics to MS progression.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!